The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

被引:1737
作者
Karran, Eric [1 ]
Mercken, Marc [1 ]
De Strooper, Bart [2 ]
机构
[1] Janssen Res & Dev, Neurosci Therapeut Area, B-2340 Beerse, Belgium
[2] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, Louvain, Belgium
关键词
GAMMA-SECRETASE INHIBITOR; GENOME-WIDE ASSOCIATION; CENTRAL-NERVOUS-SYSTEM; A-BETA; PRECURSOR PROTEIN; IN-VIVO; APOLIPOPROTEIN-E; MOUSE MODEL; PRESENILIN MUTATIONS; CLINICAL-TRIALS;
D O I
10.1038/nrd3505
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The amyloid cascade hypothesis, which posits that the deposition of the amyloid-beta peptide in the brain is a central event in Alzheimer's disease pathology, has dominated research for the past twenty years. Several therapeutics that were purported to reduce amyloid-beta production or aggregation have failed in Phase III clinical testing, and many others are in various stages of development. Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clinical trials will constitute a valid test of this hypothesis and explore whether amyloid-beta-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.
引用
收藏
页码:698 / U1600
页数:15
相关论文
共 149 条
[1]   Dynamics of Aβ Turnover and Deposition in Different β-Amyloid Precursor Protein Transgenic Mouse Models Following γ-Secretase Inhibition [J].
Abramowski, Dorothee ;
Wiederhold, Karl-Heinz ;
Furrer, Ulrich ;
Jaton, Anne-Lise ;
Neuenschwander, Anton ;
Runser, Marie-Josephine ;
Danner, Simone ;
Reichwald, Julia ;
Ammaturo, Domenico ;
Staab, Dieter ;
Stoeckli, Markus ;
Rueeger, Heinrich ;
Neumann, Ulf ;
Staufenbiel, Matthias .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 327 (02) :411-424
[2]   Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study [J].
Acosta-Baena, Natalia ;
Sepulveda-Falla, Diego ;
Mario Lopera-Gomez, Carlos ;
Cesar Jaramillo-Elorza, Mario ;
Moreno, Sonia ;
Camilo Aguirre-Acevedo, Daniel ;
Saldarriaga, Amanda ;
Lopera, Francisco .
LANCET NEUROLOGY, 2011, 10 (03) :213-220
[3]   The influence of ApoE4 on clinical progression of dementia: a meta-analysis [J].
Allan, Charlotte L. ;
Ebmeier, Klaus P. .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 26 (05) :520-526
[4]  
Alzheimer A., 1907, Zentrabl, Nervenheilk., V30, P177
[5]  
[Anonymous], 2011, SCI TRANSL MED
[6]  
[Anonymous], 2010, ALZHEIMERS DEMENT, DOI DOI 10.1016/J.JALZ.2010.05.419
[7]   The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease [J].
Arnold, Steven E. ;
Hyman, Bradley T. ;
Flory, Jill ;
Damasio, Antonio R. ;
Van Hoesen, Gary W. .
CEREBRAL CORTEX, 1991, 1 (01) :103-116
[8]   Equal Numbers of Neuronal and Nonneuronal Cells Make the Human Brain an Isometrically Scaled-Up Primate Brain [J].
Azevedo, Frederico A. C. ;
Carvalho, Ludmila R. B. ;
Grinberg, Lea T. ;
Farfel, Jose Marcelo ;
Ferretti, Renata E. L. ;
Leite, Renata E. P. ;
Jacob Filho, Wilson ;
Lent, Roberto ;
Herculano-Houzel, Suzana .
JOURNAL OF COMPARATIVE NEUROLOGY, 2009, 513 (05) :532-541
[9]   Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].
Bard, F ;
Cannon, C ;
Barbour, R ;
Burke, RL ;
Games, D ;
Grajeda, H ;
Guido, T ;
Hu, K ;
Huang, JP ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, M ;
Lieberburg, I ;
Motter, R ;
Nguyen, M ;
Soriano, F ;
Vasquez, N ;
Weiss, K ;
Welch, B ;
Seubert, P ;
Schenk, D ;
Yednock, T .
NATURE MEDICINE, 2000, 6 (08) :916-919
[10]   Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo [J].
Bateman, Randall J. ;
Munsell, Ling Y. ;
Morris, John C. ;
Swarm, Robert ;
Yarasheski, Kevin E. ;
Holtzman, David M. .
NATURE MEDICINE, 2006, 12 (07) :856-861